TDI-10229

CAS No. 2810887-45-5

TDI-10229( —— )

Catalog No. M35801 CAS No. 2810887-45-5

TDI-10229 is a potent and orally available inhibitor of soluble adenylyl cyclase (sAC, ADCY10), displaying nanomolar inhibition of sAC in both biochemical and cellular assays (IC50 = 195 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 177 In Stock
5MG 160 In Stock
10MG 236 In Stock
25MG 432 In Stock
50MG 635 In Stock
100MG 918 In Stock
200MG 1237 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TDI-10229
  • Note
    Research use only, not for human use.
  • Brief Description
    TDI-10229 is a potent and orally available inhibitor of soluble adenylyl cyclase (sAC, ADCY10), displaying nanomolar inhibition of sAC in both biochemical and cellular assays (IC50 = 195 nM).
  • Description
    TDI-10229 is a potent and orally bioavailable inhibitor of soluble adenylyl cyclase (sAC, ADCY10). TDI-10229 displays nanomolar inhibition of sAC in both biochemical and cellular assays (IC50 of 195 nM) and exhibits mouse pharmacokinetic properties sufficient to warrant its use as an in vivo tool compound.
  • In Vitro
    ——
  • In Vivo
    Animal Model:MouseDosage:20 mg/kg Administration:P.o.(Pharmacokinetic Analysis)Result:The Cmax, AUC and MRT were 15.5 μM, 94 μg h/mL and 3.95 hours, respectively.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    cAMP
  • Recptor
    cAMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2810887-45-5
  • Formula Weight
    313.78
  • Molecular Formula
    C16H16ClN5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (398.37 mM; Ultrasonic )
  • SMILES
    Cc1c(Cc2ccccc2)c(nn1C)-c1cc(Cl)nc(N)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Balbach M, et al. Soluble adenylyl cyclase inhibition prevents human sperm functions essential for fertilization [published online ahead of print, 2021 Aug 31]. Mol Hum Reprod. 2021;gaab054.?
molnova catalog
related products
  • 7-O-Methylrosmanol

    7-O-Methylrosmanol can effectively suppress FSK-induced luciferase expression under the control of the CRE, PEPCK-C and G6Pase gene promoters, it may contribute to its antihyperglycemic activity.

  • CE3F4

    CE3F4 is a selective antagonist of exchange protein directly activated by cAMP.

  • ESI-05

    ESI-05 is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation.